STOCK TITAN

The Cigna Group (CI) Stock Price, News & Analysis

CI NYSE
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
0 252 sessions, November 17, 2025 to November 17, 2026
Largest daily move
+4.7% close of February 5, 2026
1-year change
+8.4% closing prices, November 17, 2025 to November 17, 2026
1-month change
-2.7% closing prices, October 16, 2026 to November 17, 2026

Company Description

The Cigna Group (NYSE: CI) is described as a global health company that focuses on creating what it calls a better future built on the vitality of individuals and communities. According to multiple company disclosures, it positions itself around improving health, vitality, and connection for people and organizations across many markets.

The Cigna Group reports that it maintains sales capabilities in more than 30 markets and jurisdictions and has approximately or more than 180 million customer relationships worldwide, spanning medical, pharmacy, behavioral, dental and other health-related services. The company notes that its products and services are marketed under two primary brands: Cigna Healthcare and Evernorth Health Services, or their subsidiaries.

Business Structure and Segments

In its public communications and SEC filings, The Cigna Group organizes its operations into major segments that reflect its health services and health insurance activities.

Evernorth Health Services is described as the health services division of The Cigna Group. It includes the Pharmacy Benefit Services and Specialty and Care Services operating segments. Pharmacy Benefit Services focuses on pharmacy benefit management activities such as drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, and formulary management, as well as access to home delivery pharmacy. Specialty and Care Services provides specialty drugs for complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs that are intended to support whole-person health outcomes through care services.

Cigna Healthcare is the segment that encompasses the company’s health insurance and coordinated medical solutions. It includes U.S. Healthcare and International Health operating segments. U.S. Healthcare provides medical plans and other benefits and solutions for insured and self-insured clients, as well as individual health plans. International Health provides health care solutions in international markets and for globally mobile individuals and employees of multinational organizations. Company disclosures note that certain Medicare-related businesses were divested to Health Care Services Corporation in March 2025, which affected the mix of business within Cigna Healthcare.

Core Activities and Customer Relationships

The Cigna Group’s public financial reporting highlights both pharmacy customers and medical customers, as well as other relationships such as behavioral care, dental, and Medicare Part D customers. As of a recent reporting period, the company cited a total of about 182 million customer relationships, with a large base of pharmacy customers and a significant base of medical customers in the U.S. and international markets. The company emphasizes that Evernorth Health Services has been a driver of revenue growth, supported by growth of existing client relationships and specialty pharmacy volume.

In the direct health and medical insurance area, Cigna Healthcare provides medical coverage and coordinated solutions for employers, individuals, and international clients. The company’s disclosures indicate that it serves employers through insured and self-insured arrangements and offers a range of health benefits and solutions. The company also references behavioral care and dental offerings as part of its broader health relationship base.

Financial and Capital Markets Profile

The Cigna Group’s common stock trades on the New York Stock Exchange under the ticker CI. In its SEC filings, the company has described itself as issuing senior notes under an existing shelf registration statement and using proceeds for purposes such as repaying loans used to fund strategic investments and for general corporate purposes. It has also disclosed regular earnings releases and outlook affirmations, including references to adjusted income from operations as a key non-GAAP measure used by management to evaluate underlying performance.

The company has reported that its consolidated results reflect contributions from Evernorth Health Services, Cigna Healthcare, and Corporate and Other Operations. Evernorth Health Services has been cited as a significant contributor to revenue growth, while Cigna Healthcare results are influenced by medical care ratios, premium rate changes, and changes in business mix such as the divestiture of certain Medicare businesses.

Governance and Board Oversight

In an 8-K filing, The Cigna Group detailed changes to its Board committee structure to align oversight responsibilities with its strategic priorities and the evolving health services landscape. The company reported that its Compliance Committee’s responsibilities would be assumed by the full Board and other committees, and that the Audit Committee would be renamed the Audit and Compliance Committee with responsibility for enterprise compliance matters. The Corporate Governance Committee was assigned oversight of the ethics program and public clinical reporting, and oversight of clinical compliance, including patient experience and satisfaction, was designated for the full Board. The Finance Committee was renamed the Finance and Technology Committee, with oversight of technology strategy, information protection, business continuity, disaster recovery, and artificial intelligence.

The company has also reported on changes in Board membership and committee assignments through 8-K and 8-K/A filings, reflecting ongoing attention to corporate governance and Board composition.

Research, Vitality, and Purpose

The Cigna Group publishes research on topics it associates with health and vitality. In its Vitality in America reports, the company has highlighted findings about the role of purpose in health, resilience, and engagement. One such report found that fewer than one in three American adults report having a strong sense of purpose, and it linked strong purpose to higher vitality, better health, stronger relationships, and greater engagement at work. The company uses the Evernorth Vitality Index to measure aspects of competency, autonomy, and relatedness across multiple dimensions of health, including emotional, environmental, financial, intellectual, occupational, physical, purpose, and social.

These research efforts are presented as part of The Cigna Group’s focus on understanding factors that influence health and providing insights that may inform individuals, employers, and communities.

Community and Sponsorship Activities

The Cigna Group’s news releases describe several community-focused initiatives. For example, the company announced a renewed multiyear sponsorship of the Achilles Freedom Team, part of Achilles International, committing nearly $1 million over three years to support wounded veterans and athletes with disabilities in participating in major endurance races. The company has stated that it has donated more than $3 million to Achilles International since 2009 and has supported events such as the Walt Disney World Marathon Weekend and community biking events linked to honoring veterans.

These activities are presented as aligned with the company’s emphasis on health, vitality, movement, and community connection.

Evernorth Health Services and Pharmacy Benefit Innovation

Through its Evernorth Health Services division, The Cigna Group has announced initiatives in pharmacy benefit services. One notable development is a rebate-free pharmacy benefit model introduced by Evernorth’s Express Scripts pharmacy benefit services. According to company communications, this model is intended to make discounts negotiated with drug manufacturers available upfront at the point of sale, simplifying the pricing process and providing more transparent and potentially lower costs for brand-name medications.

Evernorth has also described technology that compares multiple pricing options for medications, including negotiated prices, cash discount prices, and other options, with the goal of charging the lowest available cost at the pharmacy counter. The company states that this approach is designed to help Americans, including those in high-deductible health plans, manage out-of-pocket costs while ensuring that spending counts toward deductibles and that clinical safety checks remain in place.

Additionally, Evernorth has outlined a reimbursement model for community pharmacies that is based on medication cost plus a dispensing fee and additional reimbursement tied to clinical services and quality standards, with the stated intent of supporting local pharmacies as key access points for care.

Onsite and Workplace-Based Care

In collaboration with employers, The Cigna Group, through Evernorth Health Services and its affiliates, participates in workplace-based care models. For example, a news release from Hankook Tire described the opening of the Hankook Tire Clinic Powered by Evernorth, an onsite health center at a manufacturing plant in Tennessee. Services at that clinic are provided by Evernorth Direct Health, LLC and related entities, which are part of Evernorth Health Services, the health services business of The Cigna Group. The clinic offers primary and preventive care, acute care for common conditions, chronic condition management, and certain occupational health services, with in-person and virtual visit options.

This example illustrates how Evernorth’s capabilities can be used to support employer-sponsored, onsite health solutions aimed at improving access to care and overall well-being for employees and their families.

Dividend and Capital Management

The Cigna Group’s Board of Directors has declared cash dividends on the company’s common stock, as reported in press releases and corresponding 8-K filings. These announcements provide information on dividend amounts, payment dates, and record dates. In addition, the company has disclosed the issuance of senior notes and the use of proceeds for debt repayment and general corporate purposes, indicating an active approach to capital structure management.

Stock, Sector, and Industry Context

The Cigna Group’s shares trade under the symbol CI on the New York Stock Exchange. The company is associated with the Finance and Insurance sector and the Direct Health and Medical Insurance Carriers industry classification. Its activities, however, extend beyond traditional health insurance into pharmacy benefit management, specialty pharmacy, care services, behavioral health, dental, and other health-related offerings through its Evernorth Health Services division.

Stock Performance

$294.80
+0.25%
+0.74
After hoursChange vs the $294.06 closeLast updated: at
+8.4%
Performance 1 year
$77.7B

The Cigna Group (CI) closed at $294.06 on November 17, 2026. Over the past 12 months, the price has gained 8.4%.

See what a $1,000 investment in CI would be worth today

Average down calculator for CI

CI Metrics & Rankings

Price returns through November 17, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Insider Radar

Net Sellers
90-Day Summary
0
Shares Bought
617
Shares Sold
1
Transactions
Most Recent Transaction
Neville Everett (See Remarks) sold 617 shares @ $284.05 on September 3, 2026

Insider selling at The Cigna Group over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

The Cigna Group generated $274.9B in revenue in FY2025, operating income reached $9.2B (3.4% operating margin), and net income was $6.0B, reflecting a 2.2% net profit margin. Diluted earnings per share stood at $22.18. The company generated $9.6B in operating cash flow. The current ratio was 0.85, measuring current assets divided by current liabilities.

$274.9B
Revenue (FY2025)
$6.0B
Net Income (FY2025)
$9.6B
Operating Cash Flow

Upcoming Events

DEC
01
December 1, 2026 - December 1, 2028 Corporate

Impact Fund grant term

Selected Memphis grantees receive $250,000 over two years; grant period Dec 1, 2026–Dec 1, 2028; includes annual convenings.
DEC
03
December 3, 2026 Financial

Dividend record date

Record date: shareholders of record at close of business on 2026-12-03 will be eligible for the $1.56 per share quarterly cash dividend.
DEC
17
December 17, 2026 Financial

Dividend payment

Cash dividend of $1.56 per share payable to holders of record. Payment scheduled for 2026-12-17 via standard dividend distribution channels.
DEC
31
December 31, 2026 Operations

Standardize prior authorizations

Cigna to adopt standardized e-prior authorization covering >70% of PA volume by 2026-12-31; additional services added rolling.
JAN
01
January 1, 2027 Product

Medical with Smart Coverage launch

Available Jan 1, 2027 to U.S. employer clients with 500–2,999 employees; links medical claims to supplemental cash benefits.
YEAR
2027
2027 Product

Health Sense rollout

Cigna Healthcare to begin Health Sense rollout in early 2027, initially for oncology and cardiometabolic customers; phased expansion.
YEAR
2027
2027 Product

Cigna Healthcare model adoption

Cigna Healthcare to adopt pharmacy model for fully insured lives
JAN
01
January 1, 2028 Product

Broader rollout of coverage

Planned broader rollout in 2028 to expand availability beyond mid-market clients; specific timing and markets to be announced.
YEAR
2028
2028 Product

Standardization for all clients

Model becomes standard for all Evernorth pharmacy clients

The Cigna Group has 9 upcoming scheduled events. The next event, "Impact Fund grant term", is scheduled for December 1, 2026 (in 14 days). 2 of them are financing or capital events, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the CI stock price.

Short Interest History

Last 12 Months

Short interest in The Cigna Group (CI) currently stands at 6.2 million shares, down 7.8% from the previous reporting period, representing 2.4% of the float. Since November 2025, short interest has increased by 58.4%.

Days to Cover History

Last 12 Months

Days to cover for The Cigna Group (CI) currently stands at 4.2 days, down 5.4% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 90.1%. Across the settlements charted above, it has ranged from 2.0 to 5.6 days.

CI Company Profile & Sector Positioning

The Cigna Group (CI) operates in the Healthcare Plans industry within the broader Healthcare sector and is listed on the NYSE. Among dividend-paying stocks, CI ranks #1,289 by dividend yield.

Investors comparing CI often look at related companies in the same sector, including Elevance Health, Inc. (ELV), CVS Health Corporation (CVS), Humana Inc. (HUM), Centene Corporation (CNC), and Molina Healthcare, Inc. (MOH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CI's relative position within its industry.

Frequently Asked Questions

The current stock price of The Cigna Group (CI) is $294.80 in after-hours trading as of November 17, 2026.

The market cap of The Cigna Group (CI) is approximately $77.7B. Learn more about what market capitalization means .

The FY2025 revenue of The Cigna Group (CI) is $274.9B, from its most recent completed fiscal year.

The FY2025 net income of The Cigna Group (CI) is $6.0B, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of The Cigna Group (CI) is $22.18 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of The Cigna Group (CI) is $9.6B for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of The Cigna Group (CI) is 2.2% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of The Cigna Group (CI) is 3.4% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The current ratio of The Cigna Group (CI), current assets divided by current liabilities, was 0.85 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The operating income of The Cigna Group (CI) is $9.2B for FY2025, its most recent completed fiscal year. Learn about operating income.

The Cigna Group describes itself as a global health company that offers health-related products and services through Cigna Healthcare and Evernorth Health Services. Its activities include health insurance and medical plans, pharmacy benefit services, specialty pharmacy, care services, and related health solutions.

Operationally, The Cigna Group reports two major platforms: Evernorth Health Services, which includes Pharmacy Benefit Services and Specialty and Care Services, and Cigna Healthcare, which includes U.S. Healthcare and International Health. Corporate and Other Operations are reported separately.

Evernorth Health Services is the health services division of The Cigna Group. It includes pharmacy benefit management functions such as claim adjudication and formulary management, specialty pharmacy and distribution for complex and rare diseases, and care services with clinical programs that support whole-person health outcomes.

Cigna Healthcare provides medical plans and coordinated health solutions for insured and self-insured clients, individual health plans, and international health solutions for globally mobile individuals and employees of multinational organizations.

The Cigna Group has reported approximately or more than 180 million customer relationships worldwide, including pharmacy customers, medical customers, behavioral care, dental, and other health-related relationships.

The Cigna Group’s common stock is listed on the New York Stock Exchange under the ticker symbol CI.

Company disclosures state that The Cigna Group maintains sales capabilities in more than 30 markets and jurisdictions around the world.

Through its Vitality in America reports and the Evernorth Vitality Index, The Cigna Group publishes research on topics such as purpose, vitality, and health, examining how factors like a strong sense of purpose relate to physical and mental health, relationships, and workplace engagement.

The Cigna Group reports long-standing support for initiatives such as the Achilles Freedom Team, helping wounded veterans and athletes with disabilities participate in major endurance races, and other community events that promote movement, health, and inclusion.

Yes. In an 8-K filing, The Cigna Group described changes to its Board committee structure, including discontinuing a separate Compliance Committee, renaming the Audit Committee as the Audit and Compliance Committee, assigning ethics and public clinical reporting oversight to the Corporate Governance Committee, and expanding the Finance and Technology Committee’s oversight of technology and information protection.